Header Logo

Connection

Jatin Vyas to Prospective Studies

This is a "connection" page, showing publications Jatin Vyas has written about Prospective Studies.
Connection Strength

0.095
  1. Boucau J, Glover OT, Marino C, Edelstein GE, Choudhary MC, Li Y, Leeman BM, Reynolds Z, Su K, Tien D, Mandell CB, Passell E, Alexandrescu A, Abar E, Barry M, Ghimire D, Vyas TD, Vyas JM, Lemieux JE, Li JZ, Siedner MJ, Barczak AK. Virologic characteristics of SARS-CoV-2 infection across evolving Omicron subvariants. JCI Insight. 2025 Oct 22; 10(20).
    View in: PubMed
    Score: 0.036
  2. Li Y, Choudhary MC, Regan J, Boucau J, Nathan A, Speidel T, Liew MY, Edelstein GE, Kawano Y, Uddin R, Deo R, Marino C, Getz MA, Reynolds Z, Barry M, Gilbert RF, Tien D, Sagar S, Vyas TD, Flynn JP, Hammond SP, Novack LA, Choi B, Cernadas M, Wallace ZS, Sparks JA, Vyas JM, Seaman MS, Gaiha GD, Siedner MJ, Barczak AK, Lemieux JE, Li JZ. SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency. Sci Transl Med. 2024 01 24; 16(731):eadk1599.
    View in: PubMed
    Score: 0.032
  3. North CM, Barczak A, Goldstein RH, Healy BC, Finkelstein DM, Ding DD, Kim A, Boucau J, Shaw B, Gilbert RF, Vyas T, Reynolds Z, Siddle KJ, MacInnis BL, Regan J, Flynn JP, Choudhary MC, Vyas JM, Laskowski K, Dighe AS, Lemieux JE, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA. Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination. Clin Infect Dis. 2022 04 09; 74(7):1275-1278.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.